AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Geodon for injection. (New & Approved).

OB GYN News

| August 15, 2002 | Mechcatie, Elizabeth | COPYRIGHT 2002 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(IM ziprasidone, Pfizer)

An intramuscular formulation of the atypical antipsychotic for treating acute agitation in schizophrenic patients who need an IM antipsychotic for rapid control of agitation. The first atypical antipsychotic to be approved in an IM formulation.

* Recommended Dosage: 10 mg (every 2 hours) to 20 mg (every 4 hours) as needed up to a maximum of 40 mg/day.

* Special Considerations: Contraindicated in patients with QTc prolongation, due to dose-related effect on prolongation of the QTc interval of the electrocardiogram.

In studies of oral Geodon, some patients had QTc increases, which can lead to torsades de pointes, but there were no cases of arrhythmias or sudden unexplained deaths. Modest increases in the mean QTc interval also were seen within 2 hours of the intramuscular dose, Pfizer reported at an FDA advisory panel meeting in 2001. Coadministration with oral Geodon not recommended.

* Comment: This approval "is a significant advancement in treatment options for patients who are suffering with acute agitation," said Dr. Daniel Casey, chief of psychiatric research and psychopharmacology ...

Related articles from newspapers, magazines, journals, and more
FDA Approves Injectable Form of Lilly's Zyprexa(R); Helps Control Acute...
Press release article from: PR Newswire March 30, 2004 700+ words
...the potentially crippling effects of acute agitation in patients suffering with schizophrenia...relieve patients of the effects of acute agitation without many of the debilitating side...be indicated for the treatment of acute agitation associated with both bipolar mania...
Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R)...
Press release article from: PR Newswire June 9, 2008 700+ words
...being developed for the treatment of acute agitation in patients with schizophrenia or...AZ-004 a viable product to treat acute agitation. AZ-004 is being developed through...Score is a commonly used endpoint in acute agitation studies and is the abbreviation for...
Intramuscular Olanzapine Alleviates Acute Agitation.
Magazine article from: Clinical Psychiatry News IMPERIO, WINNIE ANNE August 1, 2001 700+ words
...of action, significantly reducing acute agitation by the 30-minute mark. Of the patients...olanzapine had significantly reduced acute agitation at the subsequent assessments. Olanzapine...olanzapine significantly reduced acute agitation within 30 minutes of the first injection...
Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of...
Press release article from: PR Newswire September 2, 2008 700+ words
...loxapine) in schizophrenic patients with acute agitation. Both the 5 mg and 10 mg doses of...being developed for the treatment of acute agitation in patients with schizophrenia or...important new drug candidate for treating acute agitation." "The clinical data we have seen...
Alexza Completes Enrollment in Second Phase 3 Clinical Trial With AZ-004...
Newspaper article from: Clinical Trials Week October 27, 2008 700+ words
...Staccato(R) loxapine), treating acute agitation in patients with bipolar disorder...being developed for the treatment of acute agitation in patients with schizophrenia or...paradigm for treating patients with acute agitation." "No approved product has the...
Alexza Completes Enrollment in Second Phase 3 Clinical Trial With AZ-004...
Press release article from: PR Newswire October 16, 2008 700+ words
...Staccato(R) loxapine), treating acute agitation in patients with bipolar disorder...being developed for the treatment of acute agitation in patients with schizophrenia or...paradigm for treating patients with acute agitation." "No approved product has the...
Alexza Completes Enrollment in AZ-004 Phase IIa Clinical Trial in Schizophrenic...
Press release article from: PR Newswire January 18, 2007 700+ words
...2007." About Schizophrenic Patients with Acute Agitation Acute agitation is a complication of many major psychiatric...faster-acting, noninvasive treatment of acute agitation in schizophrenic patients. About AZ-004...
Alexza Initiates Phase IIa Clinical Trial for AZ-004 in Schizophrenic Patients...
Press release article from: PR Newswire September 22, 2006 700+ words
...clinical study. About Schizophrenic Patients with Acute Agitation Acute agitation is a complication of many major psychiatric...faster-acting, noninvasive treatment of acute agitation in schizophrenic patients. About AZ-004...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA